Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to radiation and surgery reduced relapse risk by 43%. Results showed no ...

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...

About 3 in 5 people with soft palate cancer live for at least 5 years if they receive a diagnosis and treatment before the cancer spreads. Several factors can affect survival and life expectancy. Soft ...

In patients with mostly undifferentiated pleomorphic sarcomas, 2-year DFS with the addition of preoperative and postoperative pembrolizumab (Keytruda) infusions reached 67%, as compared with 52% with ...

Soft palate cancers affect the roof of your mouth near your throat. They often go undetected until they’ve spread to other parts of your mouth. Early detection and treatment are essential to improve ...

Using 3D modeling to plan and guide cancer surgeries increases surgical precision, resulting in complete tumor removal for 92 ...

The IAEA is launching a year-long coordinated research project to develop computed tomography-based guidelines on prostate cancer contouring — a critical step in the cancer treatment process that ...

Diagnosed with rare cancer at a pivotal life moment, Nick Coleman's journey from uncertain diagnosis to cancer-free resilience inspires hope.